Umicore donates € 5,000 to the University Children’s Hospital in Würzburg

Precious Metals Chemistry

For the seventh year, materials technology and recycling group Umicore’s business unit Precious Metals Chemistry has been making an annual donation to the organization “Parents' Initiative for Children with Leukemia and Tumors Würzburg” (Elterninitiative leukämie- und tumorkranker Kinder Würzburg e.V.). This donation supports important research projects in the field of pediatric oncology at the University Children's Hospital of Würzburg, Germany. Umicore’s business unit is one of the world's leading manufacturers of high potency, metal-containing and organic active pharmaceutical ingredients (APIs) to combat cancer.

"Efficiently treating cancer is a major commitment of Umicore. Therefore, we will continue to actively work on the development of more efficient oncology products,"

says Michael Schwarz, Director Global API Business at Umicore. "Every year, the pediatric oncology department at the University Hospital of Würzburg admits around 100 children and adolescents who are newly diagnosed with cancer. With the donation we have the opportunity to help these children and young people directly."

Preparations based on precious metals such as platinum have been essential since the 1970s in the chemotherapeutic treatment of cancer. Umicore has been producing for more than 20 years oxaliplatin, carboplatin, cisplatin and a few other metal-based and organic active pharmaceutical ingredients that are important in oncology.

The “Parents' Initiative for Children with Leukemia and Tumors Würzburg” has a longstanding and close relationship with the pediatric oncology department in Würzburg and supports the young patients, their families and the clinic itself in many ways. In addition to patient care in the clinic, this includes the care and support of all involved relatives and of their environment at home. Especially in corona times, this is a very special challenge. Patient care at home offers great advantages to children and adolescents and reduces time-consuming and exhausting visits to the clinic. The University Hospital is also working on new therapeutic approaches against cancer, such as tumor vaccinations or the production of tumor-specific immune cells, in order to stop the progression of cancer types that are still incurable. 

Prof. Dr. Paul Schlegel, Head of the Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, and Jana Lorenz-Eck, member of the board of the Parents' Initiative, are pleased about this new donation and thank Umicore for this contribution.

Interested in our hAPI business or in our contribution?
Read more and contact us there!
×

      Umicore uses certain monitoring and tracking technologies such as cookies. These technologies are used in order to maintain, provide and improve our services on an ongoing basis, and in order to provide our web visitors with a better experience.

      By clicking on the "Accept all" button you agree to the use of these cookies while using the website. For further information regarding how we use cookies and other tracking technologies, please see section 11 of our website privacy notice

          Necessary cookies are essential and help you navigate our website. This helps to support security and basic functionality and are necessary for the proper operation of our website, so if you block these cookies we cannot guarantee your use or the security during your visit.

          Cookies that help us to understand the behaviour of users of our website. This allows us to continuously improve our website to provide the best information in support of our project aims. These cookies also help us understand the effectiveness of our website. For instance these cookies tell us which pages visitors go to most often and if they get error messages from web pages.

          Cookies that deliver content to you based on your interests, which are assumed from your browsing history. Most Targeting Cookies track users via their IP address and, thus, may collect some Personal Data. Personal Data collected by Targeting Cookies may be shared with third parties, such as advertisers.